Ledger.Open graph →
SEC Form D · filed April 23, 2010

Carmot Therapeutics Inc

Offering
$1.5M
Sold
$1.5M
Exemption
—
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (8)

Stig K. Hansen · San Francisco, CAExec · DirectorDaniel A. Erlanson · San Francisco, CAExec · DirectorJames A. Huang · Warrington, PADirectorMagnus Persson · San Francisco, CADirectorMark H. Handfelt · Seattle, WADirectorJames T. Hayhurst · SAANICHTON, British Columbia, CanadaExec · DirectorRichard Shipley · POWELL RIVER, British Columbia, CanadaExec · DirectorMagnus Persson · Uppsala, V7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗